{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T08:31:17Z","timestamp":1793694677992,"version":"4.5.1"},"reference-count":10,"publisher":"American Association for Cancer Research (AACR)","issue":"6","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,11,3]]},"abstract":"<jats:title>Summary:<\/jats:title>\n                  <jats:p>Zhang and colleagues uncover a mechanism of regulation of RAS stability that is active almost exclusively in hematologic (heme) malignancies. This provides new insights into the consequences of a RAS hotspot mutation found in leukemia and myeloma and points to a new therapeutic opportunity in these diseases.<\/jats:p>\n                  <jats:p>See related article by Zhang et al., p. 978<\/jats:p>","DOI":"10.1158\/2643-3230.bcd-26-0319","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:07:02Z","timestamp":1790946422000},"page":"860-862","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A (Post)translational Opportunity in RAS-Dependent Heme Malignancy"],"prefix":"10.1158","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9436-8815","authenticated-orcid":false,"given":"Lawrence H.","family":"Boise","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02gars961","id-type":"ROR","asserted-by":"publisher"}],"name":"Winship Cancer Institute of Emory University Department of Hematology and Medical Oncology, Emory School of Medicine, , Atlanta, Georgia."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2026,10,2]]},"reference":[{"key":"2026110303163768700_bib1","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1084\/jem.170.5.1715","article-title":"Ras oncogene mutation in multiple myeloma","volume":"170","author":"Neri","year":"1989","journal-title":"J Exp Med"},{"key":"2026110303163768700_bib2","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.3389\/fimmu.2019.01121","article-title":"Cell of origin and genetic alterations in the pathogenesis of multiple myeloma","volume":"10","author":"Barwick","year":"2019","journal-title":"Front Immunol"},{"key":"2026110303163768700_bib3","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1186\/s12885-025-14033-y","article-title":"The complex journey of targeting RAS in oncology","volume":"25","author":"Wasiak","year":"2025","journal-title":"BMC Cancer"},{"key":"2026110303163768700_bib4","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1158\/0008-5472.CAN-19-3682","article-title":"The frequency of Ras mutations in cancer","volume":"80","author":"Prior","year":"2020","journal-title":"Cancer Res"},{"key":"2026110303163768700_bib5","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1158\/2643-3230.BCD-26-0028","article-title":"Phosphorylation protects oncogenic RAS from LZTR1-mediated degradation","volume":"7","author":"Zhang","year":"2026","journal-title":"Blood Cancer Discov"},{"key":"2026110303163768700_bib6","doi-asserted-by":"publisher","first-page":"e202302245","DOI":"10.26508\/lsa.202302245","article-title":"Oncogenic mutations of KRAS modulate its turnover by the CUL3\/LZTR1 E3 ligase complex","volume":"7","author":"Damianou","year":"2024","journal-title":"Life Sci Alliance"},{"key":"2026110303163768700_bib7","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/s41467-025-67109-5","article-title":"Intrinsic resistance to RAS inhibitors is driven by dysregulation of KRAS degradation","volume":"17","author":"Ivanisevic","year":"2025","journal-title":"Nat Commun"},{"key":"2026110303163768700_bib8","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1056\/NEJMoa2505783","article-title":"Daraxonrasib in previously treated advanced RAS-mutated pancreatic cancer","volume":"394","author":"Wolpin","year":"2026","journal-title":"N Engl J Med"},{"key":"2026110303163768700_bib9","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1182\/bloodadvances.2019000303","article-title":"Integrated phosphoproteomics and transcriptional classifiers reveal hidden RAS signaling dynamics in multiple myeloma","volume":"3","author":"Lin","year":"2019","journal-title":"Blood Adv"},{"key":"2026110303163768700_bib10","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1182\/blood.2023022295","article-title":"RAS\/RAF landscape in monoclonal plasma cell conditions","volume":"144","author":"Schavgoulidze","year":"2024","journal-title":"Blood"}],"container-title":["Blood Cancer Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/doi\/10.1158\/2643-3230.BCD-26-0319\/3834799\/bcd-26-0319.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/7\/6\/860\/3844204\/bcd-26-0319.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article-pdf\/7\/6\/860\/3844204\/bcd-26-0319.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T08:16:42Z","timestamp":1793693802000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/bloodcancerdiscov\/article\/7\/6\/860\/789635\/A-Post-translational-Opportunity-in-RAS-Dependent"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,2]]},"references-count":10,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,10,2]]},"published-print":{"date-parts":[[2026,11,3]]}},"URL":"https:\/\/doi.org\/10.1158\/2643-3230.bcd-26-0319","relation":{},"ISSN":["2643-3230","2643-3249"],"issn-type":[{"value":"2643-3230","type":"print"},{"value":"2643-3249","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,2]]}}}